Effects of Pathway Enzyme Inhibitors and Precursors on the Anticancer Compound 1403C Synthesis in Halorosellinia sp.(No.1403)

Yu Chao,Zhou Xiangshan,Kang Li,Zou Wu,Zhang Yuanxing
DOI: https://doi.org/10.13560/j.cnki.biotech.bull.1985.2010.11.023
2010-01-01
Abstract:The biosynthetic pathway for 1403C was studied by feeding pathway specific inhibitors and biosynthetic precursors during the fermentation of Halorosellinia sp.(No.1403).Results showed that feeding of anthranilic acid and trisodium citrate,specific inhibitors of mevalonate pathway,did not inhibite 1403C yield on biomass(YP/X(1403C)).Addition of low concentration of trimethylamine,inhibitor of shikemate pathway,had no effect on YP/X(1403C)while high concentration(12 mmol/L)of trimethylamine led low YP/X(1403C)compared to the control experiment,because of the low pH in fermentation broth.Feeding of shikimate,key intermediate of shikimate pathway,did not enhance YP/X(1403C).Addition of iodoacetamide which was the specific inhibitor of the polyketide synthase strongly inhibited the 1403C production with the high inhibition rate of 94.2%.Feeding of malonic acid increased YP/X(1403C)by 59.2% compared to the control.Combined feeding of sodium acetate and malonic acid with a ratio of 1∶4 increased YP/X(1403C)by 102.7%.These results suggested that the biosynthetic pathway of 1403C involved with polyketide pathway.
What problem does this paper attempt to address?